Conditions: Osteoporosis
Keywords: Osteoporosis, oral salmon calcitonin, treatment, efficacy, tolerability
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 4665
Healthy volunteers: no

Brief summary:
The purpose of this Phase III study is to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of patients with osteoporosis

Detailed description:

Arms:
arm 1: SMC021 - Oral Calcitonin arm 2: SMC021 - placebo

Interventions: intervention 1: SMC021 Oral calcitonin intervention 2: SMC021 Placebo
Intervention descriptions: intervention 1: 0.8mg SMC021 - oral calcitonin, once daily intervention 2: SMC021 - Placebo, once daily

Protocol document: